The trademark DUALYX was filed by Dualyx NV, a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on October 4, 2023, and received one opposition filed on January 4, 2024 by ECUPHARMA SRL on Likelihood of confusion. the opponent was represented by DRAGOTTI & ASSOCIATI S.R.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued January 4, 2024
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations and substances
Immunopharmaceuticals
Vaccines
Therapeutic vaccines
Antibodies for medical purposes
None of the aforesaid goods being anti-depressants nor pharmaceutical products to treat generalized anxiety disorder (chronic feeling of anxiety or nervousness) and diabetic neuropathic pain.
The mark was filed in class 42 with following description of goods:
Laboratory services relating to the production of antibodies
Research, development and testing services in the field of antibodies for medical purposes
Research of pharmaceuticals
Testing of pharmaceuticals
Inspection of pharmaceuticals
Development of pharmaceutical preparations and medicines
Research relating to pharmaceuticals
Pharmaceutical products development
Pharmaceutical drug development services
Laboratory research services relating to pharmaceuticals